EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $110,000 | +1.9% | 1,936 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $108,000 | +10.2% | 1,936 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $98,000 | +25.6% | 1,936 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $78,000 | -27.8% | 1,936 | +23.9% | 0.00% | -25.0% |
| Q3 2018 | $108,000 | 0.0% | 1,562 | +9.2% | 0.00% | 0.0% |
| Q2 2018 | $108,000 | +44.0% | 1,430 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $75,000 | +17.2% | 1,430 | +20.4% | 0.00% | +50.0% |
| Q4 2017 | $64,000 | +10.3% | 1,188 | +22.7% | 0.00% | 0.0% |
| Q3 2017 | $58,000 | +7.4% | 968 | +41.9% | 0.00% | 0.0% |
| Q2 2017 | $54,000 | +107.7% | 682 | +121.4% | 0.00% | +100.0% |
| Q1 2017 | $26,000 | – | 308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |